CLINICAL & TRANSLATIONAL IMMUNOLOGY

 

Clinical & Translational Immunology

The Official Open Access Journal of the ASI

2024 Impact Factor: 3.8
2024 Scopus CiteScore: 9.9

Clinical & Translational Immunology cover image


CLINICAL & TRANSLATIONAL IMMUNOLOGY COVERS:
 

  • Cancer biology
  • Cardiovascular research
  • Gene therapy
  • Immunology
  • Vaccine development
  • Disease pathogenesis and therapy at the earliest phases of investigation

 

FEATURES OF CLINICAL & TRANSLATIONAL IMMUNOLOGY INCLUDE:

 

  • Rapid Review Process
  • Average Time to First Decision of 13 days (2022 manuscripts)
  • Open Access – anyone can download and read your paper 
  • Now listed on PubMed Central
  • Full peer review 
  • Original Articles, Reviews, Case Reports, Letters to Editors, Theoretical Articles, Short Communications
  • Special Features 
  • Supported by a distinguished and international Editorial Board
  • Member of COPE for responsible publication ethics  
  • Publishes only the most important advances in biomedical research
  • Eligibility for the CTI Social Impact Award

ADDITIONAL BENEFITS FOR ASI MEMBERS

  • Receive a 20% discount off the cost of publishing in CTI*
  • Be in the running for the award of ‘CTI Publication of the Year’, which also includes a speakers slot at the ASI annual meeting*** 

*Eligible only to current financial ASI members. To receive the member-only code, please contact us. For further information about the Wiley-CAUL agreement, which covers the APC (Article Processing Charge) for authors, see https://authorservices.wiley.com/author-resources/Journal-Authors/open-access/affiliation-policies-payments/institutional-funder-payments.html
***Awarded to the best publication from a current financial ASI member who is first author.

GREAT REASONS TO SUBMIT TO CTI

Click to download the CTI slide (pptx) and display it at your next meeting presentation.

CTI website Submit a manuscript

Follow us on Twitter @ClinTransImmuno 

© ASI 2021

ABN 76 330 189 856 | ARBN 084 971 559 | CAV A0016266B